World Without Cancer_ The Story of Vitamin B17

Chapter 1. THE WATERGATE SYNDROME 21
Examples of dishonesty and corruption in the field of drug
research; a close look at the first major study which declared
Laetrile (vitamin B17) "of no value;" proof that the study was
fraudulent; the FDA's ruling against the use of Laetrile because it
had not been tested; and the refusal then to allow anyone (except
its opponents) to test it.
Chapter 2. GENOCIDE IN MANHATTAN 37
Continued attempts by the cancer industry to prove that
Laetrile is worthless; the suppressed lab reports from the Sloan-
Kettering Institute which proved that Laetrile does work; the
Rockefeller connection to the pharmaceutical industry; the story
of how a group of employees at Sloan-Kettering leaked the truth
to the outside world.
Chapter 3. AN APPLE A DAY 53
A review of entrenched scientific error in history; the vitamindeficiency
concept of cancer as advanced in 1952 by Dr. Ernst T.
Krebs, Jr.; and a survey of the evidence both in nature and in
history to support that concept.
Chapter 4. THE ULTIMATE TEST 63
A look at the many cultures around the world that are, or
have been, free from cancer; and an analysis of their native foods.
Chapter 5. CANCER: THE ONRUSH OF LIFE 75
An explanation of the trophoblast thesis of cancer; a description
of a simple urine test for cancer; an appraisal of BCG vaccine
as an anti-cancer agent; and a review of the vital role played by
the pancreas in the control of cancer.
Chapter 6. THE TOTAL MECHANISM 85
The nutritional factor as a back-up mechanism to the enzyme
factor; a biographical sketch of Dr. Ernst T. Krebs, Jr., and his
development of Laetrile; the beneficial secondary effects of vitamin
B17 on a wide range of human disorders; and an appraisal of
the complexity of nature's total natural anti-cancer mechanism.
Chapter 7. THE CYANIDE SCARE 95
A newspaper account of a couple who reportedly were
poisoned by eating apricot kernels; a close look at the facts in this
case; an evaluation of the toxic potential of seeds containing B17;
and the clinical evidence that Laetrile is less toxic than sugar.
Chapter 8. THE LAETRILE "QUACKS" . . . . . . . . 105
The names, professional standings, medical achievements,
and clinical findings of some of the more prominent doctors who
endorse Laetrile; the beneficial side-effects produced by its use; a
suggested anti-cancer diet; and a brief description of vitamin B15.
Chapter 9. "UNPROVEN" CANCER CURES 115
Clinical evidence in support of the trophoblast thesis; laboratory
experiments showing that Laetrile kills cancer cells; and case
histories of terminal cancer patients who attribute their recovery
to the effect of Laetrile.
Chapter 10. "PROVEN" CANCER CURES 137
The effects of surgery and radiation in the treatment of cancer
patients; a comparison showing that those who receive no
treatment at all live just as long, if not longer, than those who are
treated.
Chapter 11. A NEW DIMENSION OF MURDER . . . . 151
Anti-cancer drugs shown to be ineffective and cancer-causing;
FDA-approved experiments on humans resulting in death from
drugs rather than from cancer.
Chapter 12. A STATISTICAL COMPARISON 165
The inherent weaknesses of all cancer statistics; the need for
statistical comparisons in spite of those weaknesses; a comparison
of the results obtained by orthodox and Laetrile physicians;
and the consequences of consensus medicine.
PART TWO
THE POLITICS OF CANCER THERAPY
Chapter 13. CARTELS—ESCAPE FROM COMPETITION 177
A review of the science of cancer therapy; a summary of the
politics of cancer therapy; the early history of the I.G. Farben
chemical and pharmaceutical cartel; the cartel's early success in
the United States; and its "marriage" with DuPont, Standard Oil,
and Ford.
Chapter 14. THE ULTIMATE MONOPOLY 193
Early examples of cartel support for totalitarian regimes; I.G.
Farben's role in lifting Hitler out of political oblivion and
converting the Nazi state into an instrument of cartel power.
Chapter 15. WAR GAMES 203
Germany's industrial preparations for World War II; the
continued support by American industrialists given to Farben
and to the Nazi regime during this period; and the profitable role
played by Ford and ITT in war production for both Nazi
Germany and the United States.
Chapter 16. CONSPIRACY 211
Efforts to camouflage Farben ownership of firms in America;
the assistance rendered by Rockefeller interests; penetration into
the U.S. government by agents of the cartel; and the final
disposition of the Farben case.
Chapter 17. THE ROCKEFELLER GROUP 227
A biographical sketch of John D. Rockefeller, Sr., and his
crusade against free-enterprise; the beginning of Standard Oil;
the entry of the Rockefellers into investment banking; their
influence in the pharmaceutical industry and international politics.
Chapter 18. THE CHARITY PRESCRIPTION 247
The drug cartel's influence over the nation's medical schools;
the drug-oriented training given to all medical students; and the
use of philanthropic foundations to obtain control over educational
institutions.
Chapter 19. HE WHO PAYS THE PIPER 261
The low state of medical education in the U.S. prior to 1910;
the role of the Flexner Report in dramatizing the need for reform;
the role played by the Rockefeller and Carnegie foundations in
implementing the Flexner Report; and the use of foundation
funding as a means of gaining control over American medical
schools.
Chapter 20. HE WHO CALLS THE TUNE 269
AMA influence over the practice of medicine in America; how
the leadership of the AMA keeps control away from its members;
AMA funding by the drug industry; and examples of interlock
between the two.
Chapter 21. THE PROTECTION RACKET 277
Cartel agents in the FDA and other agencies of government;
the CFR as a control structure over U.S. foreign policy; scientific
ineptitude at the FDA; and the growth of FDA power.
Chapter 22. THE ARSENAL OF COMPLIANCE . . . . 293
Government harassment of the nutrition and vitamin industry;
the role played by the media in discrediting Laetrile in the
public mind; and a comparison of the cost of Laetrile therapy
with that of orthodox cancer treatments.
Chapter 23. THE DOUBLE STANDARD 303
An analysis of the FDA's double standard in which harmless
non-drug materials such as vitamins and food supplements are
burdened with restrictions in excess of those applied to toxic and
dangerous drugs.
Chapter 24. TO WALK THE HIGHEST WIRE 315
How doctors are intimidated into not using Laetrile; why the
pharmaceutical industry seeks a patentable substitute for
Laetrile; and the courageous stand against the FDA and AMA by
Laetrile doctors.
Chapter 25. A QUESTION OF MOTIVES 329
What has motivated opposition to Laetrile therapy; the
limited" vs. "total" conspiracy theories; and the grass-roots
backlash as a force for change.
Chapter 26. A WORLD WITHOUT CANCER 349
Areas of need for further research with vitamin B17; how the
Laetrile controversy differs from medical controversies of the
past; an analogy of biological and political cancer; and a scenario
in which both will be conquered together.
First Photo Section 129-136
Second Photo Section 239-246
Bibliography 359
Index